Latest News

Find out the latest on Professor Saeed’s work.

Audion Therapeutics and REGAIN Consortium announce positive Phase I Results in patients with sensorineural hearing loss

The REGAIN consortium, led by Audion Therapeutics BV, a company dedicated to the development of therapeutics for hearing loss, today reports positive results from its Phase I multiple ascending dose, open-label safety study of the Notch Inhibitor LY3056480 in 15 patients with mild to moderate sensorineural hearing loss

In The Press

More on Prof Saeed’s work in the press

On-Going Research

Read more on Prof. Saeed’s Research endeavors

Make an appointment

For patients seeking advice or a consultation, feel free to contact Prof. Saeed’s office

Contact Us